Evaluation of human natural killer cell activities in whole blood

Current Protocols in Immunology

Volumn , Issue SUPPL.91, 2010, Pages

  Claus, Maren ^a   Watzl, Carsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cytokine production; Cytotoxicity; Degranulation; Natural killer cells

Indexed keywords

CHROMIUM 51;

ARTICLE; BLOOD ANALYSIS; CELL ACTIVATION; CELL FUNCTION; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXICITY; DEGRANULATION; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INNATE IMMUNITY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STAINING;

EID: 79953199125     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im0739s91     Document Type: Article

References (17)

1. Alter, G., Malenfant, J.M., and Altfeld, M. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294:15-22.
2. Aste-Amezaga, M., D'Andrea, A., Kubin, M., and Trinchieri, G. 1994. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol. 156:480-492.
3. Biron, C.A. and Brossay, L. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:458-464.
4. Claus, M., Greil, J., and Watzl, C. 2009. Comprehensive analysis of NK cell function in whole blood samples. J. Immunol. Methods 341:154-164.
5. Hefeneider, S.H., Conlon, P.J., Henney, C.S., and Gillis, S. 1983. In vivo interleukin 2 administration augments the generation of alloreactive cy-tolytic T lymphocytes and resident natural killer cells. J. Immunol. 130:222-227.
6. Imai, K., Matsuyama, S., Miyake, S., Suga, K., and Nakachi, K. 2000. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up study of a general population. Lancet 356:1795-1799.
7. Kiessling, R., Klein, E., and Wigzell, H. 1975. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5:112-117.
8. Lanier, L.L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
9. Lauwerys, B.R., Garot, N., Renauld, J.C., and Houssiau, F.A. 2000. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J. Immunol. 165:1847-1853.
10. Ljunggren, H.G. and Malmberg, K.J. 2007. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7:329-339.
11. Long, E.O., Barber, D.F., Burshtyn, D.N., Faure, M., Peterson, M., Rajagopalan, S., Renard, V., Sandusky, M., Stebbins, C.C., Wagtmann, N., and Watzl, C. 2001. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol. Rev. 181:223-233.
12. Moretta, L. and Moretta, A. 2004. Unravelling natural killer cell function: Triggering and inhibitory human NK receptors. EMBO J. 23:255-259.
13. Moretta, L., Ferlazzo, G., Bottino, C., Vitale, M., Pende, D., Mingari, M.C., and Moretta, A. 2006. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 214:219-228.
14. Ruggeri, L., Mancusi, A., Burchielli, E., Aversa, F., Martelli, M.F., and Velardi, A. 2007. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr. Opin. Oncol. 19:142-147.
15. Siegel, J.P., Sharon, M., Smith, P.L., and Leonard, W.J. 1987. The IL-2 receptor beta chain (p70): Role in mediating signals for LAK, NK, and proliferative activities. Science 238:75-78.
16. Wu, J. and Lanier, L.L. 2003. Natural killer cells and cancer. Adv. Cancer Res. 90:127-156.
17. Zamai, L., Ponti, C., Mirandola, P., Gobbi, G., Papa, S., Galeotti, L., Cocco, L., and Vitale, M. 2007. NK cells and cancer. J. Immunol. 178:4011-4016.